Short duration of neutralizing antibody titers after pre-exposure rabies vaccination with suckling mouse brain vaccine

Brazilian Journal of Medical and Biological Research

Volumn 31, Issue 10, 1998, Pages 1275-1280

  Zanetti, C R ^a,d   Consales, C A ^b   Rodrigues da Silva, A C ^b   Toyoshima, Y K ^c   Pereira, O A C ^b  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b Instituto Pasteur de Sao Paulo   (Brazil)

^c Secretaria da Acao Social J   (Brazil)

^d CCB   (Brazil)

Author keywords

Pre exposure; Rabies; Rabies vaccine; Suckling mouse brain vaccine

Indexed keywords

RABIES VACCINE; SUCKLING MOUSE BRAIN VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CELL CULTURE; CLINICAL TRIAL; DOSE RESPONSE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; RABIES; RABIES VIRUS; SEROCONVERSION; VACCINATION; VACCINE PRODUCTION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

RABIES VIRUS;

EID: 0031757584     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1998001000007     Document Type: Article

References (16)

1. WHO (1992). Expert Committee on Rabies. 8th report. Technical Report Series No. 824. World Health Organization, Geneva.
2. Favoretto SR, Carrieri ML, Tino MS, Zanetti CR & Pereira OAC (1993). Simplified fluorescence inhibition microtest for the titration of rabies neutralizing antibodies. Revista do Institute de Medicina Tropical de Sāo Paulo, 35: 171-175.
3. Zanetti CR, Lee LM, Chaves LB, Rodrigues JL, Eleutério GC & Pereira OAC (1995) Studies on human anti-rabies immunization in Brazil. Preliminary evaluation of the 00-7-21 schedule for human anti-rabies immunization, employing suckling mouse brain vaccine. Revista do Instituto de Medicine Tropical de Sāo Paulo, 37: 353-356.
4. Zanetti CR, Chaves LB, Rodrigues Da Silva AC, Lee LM & Pereira OAC (1995). Studies on human anti-rabies immunization in Brazil. I - Evaluation of the 0-2-4-28 pre-exposure vaccination schedule under field conditions Revista do Institute de Medicina Tropical de Sāo Paulo, 37: 349a-352a
5. Chamelet ELB, Azevedo MP, Favoretto SR, Kerbrie SV & Souza LTM (1982). Esquema reduzido de vacinaçāo antirábica humana pré-exposiçāo e avaliaçāo de doses anuais de reforço. Revista de Saúde Pública de Sāo Paulo, 16: 144-148.
6. Favoretto SR, Carrieri ML, Tino MS, Zanetti CR & Pereira OAC (1993). Reduced schedule of human anti-rabies immunization with Fuenzalida and Palacios vaccine. Additional data. Revista do Institute de Medicina Tropical de Sāo Paulo, 35: 281-284.
7. Fuenzalida E & Palacios R (1955). Un método mejorado en la preparación de la vacuna antirábica. Boletín del Instituto de Bacteriologia de Chile, 8: 3-10.
8. Barth R, Gross-Albenhausen E, Jaeger O & Milcke L (1981). The antibody-binding test, a useful method for quantitative determination of inactivated rabies virus antigen Journal of Biological Standardization, 9: 81-89.
9. Albas A, Mourão Fuches RM & Frazatti Galina NM (1992) Termoestabilidade da vacina contra a raiva, tipo Fuenzalida & Palacios, uso humano. Revista do Instituto de Medicina Tropical de Sāo Paulo, 34: 27-31.
10. Held RJ & Adaros LH (1972). Neurological disease in man following administration of suckling mouse brain anti-rabies vaccine. Bulletin of the World Health Organization, 46: 321-327.
11. Lafon M, Bourhy H & Sureau P (1988). Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccine: an experimental study in mice. Vaccine, 6: 362-368.
12. Tordo N, Sacramento D & Bourhy H (1996). The polymerase chain reaction (PCR) technique for diagnosis, typing and epidemiological studies of rabies. In: Meslin F-X, Kaplan MM & Koprowski H (Editors), Laboratory Techniques in Rabies 4th edn. World Health Organization, Geneva.
13. Vodopijal, Sureau P & Lafon M (1986). An evaluation of second generation tissue culture rabies vaccines for use in humans: a four vaccine comparative immunogenicity study using a pre-exposure vaccination schedule and an abbreviated 00-7-21 post-exposure schedule. Vaccine, 44: 245-248
14. Vodopija I. Sureau P & Smerdel S (1988). Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 00-7-21 schedule application for post-exposure treatment Vaccine. 6: 283-286.
15. Chavenet P, Sureau P & Waldner-Combernoux A (1989). Schéma simplifié pour la vaccination antirabique après exposition Presse Médicale, 18: 813-815.
16. World Survey of Rabies for the year 1994 (No. 30), WHO/EMC/ZOO/96.3. World Health Organization, Geneva.